rs199648534
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_152383.5(DIS3L2):c.733C>T(p.Arg245*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,736 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_152383.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIS3L2 | NM_152383.5 | c.733C>T | p.Arg245* | stop_gained | 8/21 | ENST00000325385.12 | NP_689596.4 | |
DIS3L2 | NM_001257281.2 | c.733C>T | p.Arg245* | stop_gained | 8/14 | NP_001244210.1 | ||
DIS3L2 | NR_046476.2 | n.879C>T | non_coding_transcript_exon_variant | 8/21 | ||||
DIS3L2 | NR_046477.2 | n.1072+5559C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIS3L2 | ENST00000325385.12 | c.733C>T | p.Arg245* | stop_gained | 8/21 | 5 | NM_152383.5 | ENSP00000315569.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249258Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135218
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461736Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727164
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Perlman syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 14, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 581845). This variant has not been reported in the literature in individuals affected with DIS3L2-related conditions. This variant is present in population databases (rs199648534, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg245*) in the DIS3L2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DIS3L2 are known to be pathogenic (PMID: 22306653, 28328139). - |
DIS3L2-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 01, 2024 | The DIS3L2 c.733C>T variant is predicted to result in premature protein termination (p.Arg245*). This variant was identified in an individual with liver hepatocellular carcinoma (TableS2B, Huang et al 2018. PubMed ID: 29625052; TableS2B, Yang Y et al 2022. PubMed ID: 36451132). In ClinVar this variant is interpreted as either likely pathogenic or pathogenic by multiple labs (https://www.ncbi.nlm.nih.gov/clinvar/variation/581845/). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in DIS3L2 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at